scispace - formally typeset
Open AccessJournal ArticleDOI

Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy.

Reads0
Chats0
TLDR
Both apoptotic and nonapoptotic pathways activated by TRAIL are summarized, as well as recent advances in developing TRAIL–receptor agonists for cancer therapy.

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Evidence for the Involvement of the Master Transcription Factor NF-κB in Cancer Initiation and Progression.

TL;DR: Although NF-κB has been identified to be a major contributor to cancer initiation and development, there is evidence revealing its role in tumor suppression, as well as a few important pharmacological strategies that have been developed to modulate NF-σB function.
Journal ArticleDOI

MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis

TL;DR: Better understanding the cancer type-specific expression of apoptomiRs and oncomiRs and their underlying mechanisms in cell death pathways will not only advance the knowledge, but also continue to provide new opportunities to treat cancer.
References
More filters
Journal ArticleDOI

Hallmarks of cancer: the next generation.

TL;DR: Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.
Journal ArticleDOI

An endotoxin-induced serum factor that causes necrosis of tumors

TL;DR: It is proposed that TNF mediates endotoxin-induced tumor necrosis, and that it may be responsible for the suppression of transformed cells by activated macrophages.
Journal ArticleDOI

Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors

TL;DR: The purification of a cytosolic protein that induces cytochrome c release from mitochondria in response to caspase-8, the apical caspases activated by cell surface death receptors such as Fas and TNF is reported.
Journal ArticleDOI

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition.

TL;DR: The identification of a novel protein, Smac, which promotes caspase activation in the cytochrome c/Apaf-1/caspase-9 pathway and increases cells' sensitivity to apoptotic stimuli is reported.
Related Papers (5)